Search results
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Bristol Myers (BMY) Gets EU Nod for Anemia Drug Reblozyl
Zacks via Yahoo News· 1 year agoBristol Myers Squibb (BMY) gets full marketing authorization from the European Commission, for...
Casgevy: World-first gene therapy for sickle cell disease approved in UK
Evening Standard via Yahoo News· 8 months agoThe UK’s medical regulator on Thursday approved the world’s first gene therapy that aims to cure...
bluebird (BLUE) Up 101% in the Past Three Months: Here's Why
Zacks via Yahoo News· 2 years agobluebird bio (BLUE) has surged in the past three months owing to its pipeline development. The...
Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia
Zacks via Yahoo News· 6 months agoThis is the second approval granted to Vertex (VRTX)/CRISPR's (CRSP) gene therapy Casgevy and comes...
bluebird (BLUE) Up on Positive Data on Gene Therapies at ASH
Zacks via Yahoo News· 2 years agoShares of bluebird bio, Inc. BLUE gained 7.74% on Dec 12 after the company announced new and updated...
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Zacks via Yahoo News· 1 week agoVertex Pharmaceuticals Incorporated VRTX has been witnessing strong revenue growth, regulatory...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo News· 3 weeks agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo News· 4 weeks agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
bluebird bio (BLUE) Focused on Pipeline Amid Marketed Drug Dearth
Zacks via Yahoo News· 2 years agobluebird bio's (BLUE) efforts to develop its gene-therapy pipeline are impressive. The FDA is...